Rolph Timothy - Insider Non-Derivative Transactions at Akero Therapeutics, Inc. (AKRO) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 10, 2024, Rolph Timothy's relationship to Akero Therapeutics, Inc. (AKRO) is Officer (Chief Scientific Officer), and currently has 180,705 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other AKRO insiders.

Data Source: SEC.
Rolph Timothy - Insider Non-Derivative Transactions of AKRO Common Stock
Rolph Timothy - Insider Non-Derivative Transactions at AKRO
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 11, 2024 Sell -- (Common Stock) 537 26.18 180705
Jun 29, 2024 Acquisition -- (Common Stock) 1064 19.94 181242
Jun 12, 2024 Sell -- (Common Stock) 2380 22.64 180178
Mar 14, 2024 Sell -- (Common Stock) 619 28.33 182558
Dec 15, 2023 Sell -- (Common Stock) 514 20.76 182672
Dec 9, 2023 Acquisition -- (Common Stock) 32497 0 183186
Sep 14, 2023 Sell -- (Common Stock) 531 50.34 150689
Jun 17, 2023 Sell -- (Common Stock) 1413 56.3 151220
Jun 17, 2023 Sell -- (Common Stock) 27462 55.08 152633
Jun 17, 2023 Sell -- (Common Stock) 49325 54.58 180095
Jun 17, 2023 M -- (Common Stock) 40000 0.61 229420
Jun 14, 2023 Sell -- (Common Stock) 509 55.16 189420
Mar 11, 2023 F -- (Common Stock) 603 43.47 189929